Ruxolitinib for the treatment of myelofibrosis: its clinical potential

• Asıl Yazarlar: Ostojic A (Yazar), Vrhovac R (Yazar), Verstovsek S (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Dove Medical Press, 2012-03-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Alen Ostojic1, Radovan Vrhovac1, Srdan Verstovsek21Division of Hematology, Department of Internal Medicine, University Hospital Center Zagreb, Zagreb, Croatia; 2Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, TX, USAAbstract: Ruxolitinib is an orally bioavailable, se...